Alterity Therapeutics Ltd ADR (ATHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2022 | 06-2022 | 12-2021 | 06-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,283 | -9,321 | -4,796 | -11,439 | 6,263 |
| Depreciation Amortization | 33 | 39 | -23 | 56 | 26 |
| Other Working Capital | -1,394 | 1,279 | 1,294 | -3,214 | -1,001 |
| Other Operating Activity | 117 | -948 | -2,793 | 1,648 | 74 |
| Operating Cash Flow | $-6,527 | $-8,951 | $-6,318 | $-12,949 | $5,362 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -65 | -2 | -8 | -2 |
| Investing Cash Flow | $-3 | $-65 | $-2 | $-8 | $-2 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 8 | 11,829 | 11,906 | 27,412 | 24,992 |
| Financing Cash Flow | $8 | $11,829 | $11,906 | $27,412 | $24,992 |
| Exchange Rate Effect | 295 | 2,041 | 888 | -319 | -722 |
| Beginning Cash Position | 22,892 | 20,398 | 20,482 | 6,872 | 6,728 |
| End Cash Position | 16,665 | 25,252 | 26,956 | 21,008 | 25,633 |
| Net Cash Flow | $-6,227 | $4,855 | $6,474 | $14,136 | $18,906 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,527 | -8,951 | -6,318 | -12,949 | 5,362 |
| Free Cash Flow | -6,527 | -8,951 | -6,318 | -12,949 | 5,362 |